A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal Ring
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The proposed study is a single-center, double-blind, randomised, placebo-controlled trial to
evaluate the delivery of dapivirine from matrix vaginal rings over a 56 and 57 day period and
to assess the safety as compared to placebo vaginal rings in 48 healthy, HIV-negative,
sexually active women.